ZHEJIANG SHENGDA BIO-PHARM CO., LTD financial statements, including revenue, expenses, profit, and loss

The total revenue of 603079 for the last quarter is 182.58 M CNY, and it's 1.03% higher compared to the previous quarter. The net income of Q1 24 is 3.81 M CNY.